The North America Acute Myeloid Leukemia Market is witnessing steady growth owing to increasing investments in oncology research, expanding access to advanced treatment options, and strong healthcare infrastructure across the region. The growing adoption of targeted therapies, immunotherapies, and precision medicine is transforming the treatment landscape for acute myeloid leukemia patients....